|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prahm KP, Novotny GW, Høgdall C and
Høgdall E: Current status on microRNAs as biomarkers for ovarian
cancer. APMIS. 124:337–355. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yeung TL, Leung CS, Yip KP, Au Yeung CL,
Wong ST and Mok SC: Cellular and molecular processes in ovarian
cancer metastasis. A review in the theme: Cell and molecular
processes in cancer metastasis. Am J Physiol Cell Physiol.
309:C444–C456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Y, Kim S and Kim IM: Regulation of
metastasis by microRNAs in ovarian cancer. Front Oncol. 4:1432014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang L, Nadeem L, Connor K and Xu G:
Mechanisms and therapeutic targets of microRNA-associated
chemoresistance in epithelial ovarian cancer. Curr Cancer Drug
Targets. 16:429–441. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang ZH and Xu CJ: Research progress of
MicroRNA in early detection of ovarian cancer. Chin Med J (Engl).
128:3363–3370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Langhe R: microRNA and ovarian cancer. Adv
Exp Med Biol. 889:119–151. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wei J, Zhang L, Li J, Zhu S, Tai M, Mason
CW, Chapman JA, Reynolds EA, Weiner CP and Zhou HH: MicroRNA-205
promotes cell invasion by repressing TCF21 in human ovarian cancer.
J Ovarian Res. 10:332017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei LQ, Liang HT, Qin DC, Jin HF, Zhao Y
and She MC: MiR-212 exerts suppressive effect on SKOV3 ovarian
cancer cells through targeting HBEGF. Tumour Biol. 35:12427–12434.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hanlon K, Rudin CE and Harries LW:
Investigating the targets of MIR-15a and MIR-16-1 in patients with
chronic lymphocytic leukemia (CLL). PLoS One. 4:e71692009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bottoni A, Piccin D, Tagliati F, Luchin A,
Zatelli MC and degli Uberti EC: miR-15a and miR-16-1
down-regulation in pituitary adenomas. J Cell Physiol. 204:280–285.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Di Leva G and Croce CM: The role of
microRNAs in the tumorigenesis of ovarian cancer. Front Oncol.
3:1532013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bhattacharya R, Nicoloso M, Arvizo R, Wang
E, Cortez A, Rossi S, Calin GA and Mukherjee P: MiR-15a and MiR-16
control Bmi-1 expression in ovarian cancer. Cancer Res.
69:9090–9095. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pietruszewska W, Bojanowska-Poźniak K and
Kobos J: Matrix metalloproteinases MMP1, MMP2, MMP9 and their
tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: An
immunohistochemical study. Otolaryngol Pol. 70:32–43. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deng J, Wang L, Chen H, Hao J, Ni J, Chang
L, Duan W, Graham P and Li Y: Targeting epithelial-mesenchymal
transition and cancer stem cells for chemoresistant ovarian cancer.
Oncotarget. 7:55771–55788. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou XM, Zhang H and Han X: Role of
epithelial to mesenchymal transition proteins in gynecological
cancers: Pathological and therapeutic perspectives. Tumour Biol.
35:9523–9530. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
McCubrey JA, Fitzgerald TL, Yang LV,
Lertpiriyapong K, Steelman LS, Abrams SL, Montalto G, Cervello M,
Neri LM, Cocco L, et al: Roles of GSK-3 and microRNAs on epithelial
mesenchymal transition and cancer stem cells. Oncotarget.
8:14221–14250. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ghahhari NM and Babashah S: Interplay
between microRNAs and WNT/β-catenin signalling pathway regulates
epithelial-mesenchymal transition in cancer. Eur J Cancer.
51:1638–1649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu L and Fang J: The structure and
clinical roles of MicroRNA in colorectal cancer. Gastroenterol Res
Pract. 2016:13603482016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shukla KK, Misra S, Pareek P, Mishra V,
Singhal B and Sharma P: Recent scenario of microRNA as diagnostic
and prognostic biomarkers of prostate cancer. Urol Oncol.
35:92–101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shah MY, Ferrajoli A, Sood AK,
Lopez-Berestein G and Calin GA: microRNA therapeutics in cancer-an
emerging concept. EBioMedicine. 12:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pal MK, Jaiswar SP, Dwivedi VN, Tripathi
AK, Dwivedi A and Sankhwar P: MicroRNA: A new and promising
potential biomarker for diagnosis and prognosis of ovarian cancer.
Cancer Biol Med. 12:328–341. 2015.PubMed/NCBI
|
|
24
|
Li X, Ling N, Bai Y, Dong W, Hui GZ, Liu
D, Zhao J and Hu J: MiR-16-1 plays a role in reducing migration and
invasion of glioma cells. Anat Rec (Hoboken). 296:427–432. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu WL, Wang WY, Yao WQ and Li GD:
Suppressive effects of microRNA-16 on the proliferation, invasion
and metastasis of hepatocellular carcinoma cells. Int J Mol Med.
36:1713–1719. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ekinci T, Ozbay PO, Yiğit S, Yavuzcan A,
Uysal S and Soylu F: The correlation between immunohistochemical
expression of MMP-2 and the prognosis of epithelial ovarian cancer.
Ginekol Pol. 85:121–130. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tan H, He Q, Gong G, Wang Y, Li J, Wang J,
Zhu D and Wu X: miR-382 inhibits migration and invasion by
targeting ROR1 through regulating EMT in ovarian cancer. Int J
Oncol. 48:181–190. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Amankwah EK, Lin HY, Tyrer JP, Lawrenson
K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N,
Bruinsma F, et al: Epithelial-mesenchymal transition (EMT) gene
variants and epithelial ovarian cancer (EOC) risk. Genet Epidemiol.
39:689–697. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takai M, Terai Y, Kawaguchi H, Ashihara K,
Fujiwara S, Tanaka T, Tsunetoh S, Tanaka Y, Sasaki H, Kanemura M,
et al: The EMT (epithelial-mesenchymal-transition)-related protein
expression indicates the metastatic status and prognosis in
patients with ovarian cancer. J Ovarian Res. 7:762014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Q, Li X, Zhu Y and Yang P:
MicroRNA-16 suppresses epithelial-mesenchymal transition-related
gene expression in human glioma. Mol Med Rep. 10:3310–3314. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang H, Zhang Y, Wu Q, Wang Y-B and Wang
W: miR-16 mimics inhibit TGF-β1-induced epithelial-to-mesenchymal
transition via activation of autophagy in non-small cell lung
carcinoma cells. Oncol Rep. 39:247–254. 2018.PubMed/NCBI
|
|
32
|
Bodnar L, Stanczak A, Cierniak S, Smoter
M, Cichowicz M, Kozlowski W, Szczylik C, Wieczorek M and
Lamparska-Przybysz M: Wnt/β-catenin pathway as a potential
prognostic and predictive marker in patients with advanced ovarian
cancer. J Ovarian Res. 7:162014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Arend RC, Londoño-Joshi AI, Straughn JM
Jr..Buchsbaum DJ: The Wnt/β-catenin pathway in ovarian cancer: A
review. Gynecol Oncol. 131:772–779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu Y, Ginther C, Kim J, Mosher N, Chung S,
Slamon D and Vadgama JV: Expression of Wnt3 activates Wnt/β-catenin
pathway and promotes EMT-like phenotype in trastuzumab-resistant
HER2-overexpressing breast cancer cells. Mol Cancer Res.
10:1597–1606. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kwon YJ, Baek HS, Ye DJ, Shin S, Kim D and
Chun YJ: CYP1B1 enhances cell proliferation and metastasis through
induction of EMT and activation of Wnt/β-catenin signaling via Sp1
upregulation. PLoS One. 11:e01515982016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sonderegger S, Haslinger P, Sabri A,
Leisser C, Otten JV, Fiala C and Knöfler M: Wingless (Wnt)-3A
induces trophoblast migration and matrix metalloproteinase-2
secretion through canonical Wnt signaling and protein kinase B/AKT
activation. Endocrinology. 151:211–220. 2010. View Article : Google Scholar : PubMed/NCBI
|
